To investigate the serum concentration of soluble Fas(sFas) in patients with Graves? disease(GD), serum sFas was determined by solid phase sandwich enzyme-linked immunosorbent assay(ELISA) in 58 patients with GD.
英
美
- 為探討Graves病 (GD)患者血清可溶性凋亡相關(guān)蛋白Fas(sFas)的水平及臨床意義 ,應用固相ELISA法檢測了 5 8例GD患者和 2 2名正常對照組血清sFas含量。